ZA200202851B - A DNA molecule encoding a variant alpha2B-adrenoceptor protein, and uses thereof. - Google Patents
A DNA molecule encoding a variant alpha2B-adrenoceptor protein, and uses thereof.Info
- Publication number
- ZA200202851B ZA200202851B ZA200202851A ZA200202851A ZA200202851B ZA 200202851 B ZA200202851 B ZA 200202851B ZA 200202851 A ZA200202851 A ZA 200202851A ZA 200202851 A ZA200202851 A ZA 200202851A ZA 200202851 B ZA200202851 B ZA 200202851B
- Authority
- ZA
- South Africa
- Prior art keywords
- alpha2b
- variant
- dna molecule
- molecule encoding
- adrenoceptor protein
- Prior art date
Links
- 102000008841 Alpha 2B adrenoceptor Human genes 0.000 title 1
- 108050000738 Alpha 2B adrenoceptor Proteins 0.000 title 1
- 108020004414 DNA Proteins 0.000 title 1
- 102000053602 DNA Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42298599A | 1999-10-22 | 1999-10-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200202851B true ZA200202851B (en) | 2003-09-23 |
Family
ID=23677216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200202851A ZA200202851B (en) | 1999-10-22 | 2002-04-11 | A DNA molecule encoding a variant alpha2B-adrenoceptor protein, and uses thereof. |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6696556B2 (xx) |
| EP (1) | EP1222204A1 (xx) |
| JP (1) | JP2003512040A (xx) |
| CA (1) | CA2387962A1 (xx) |
| HK (1) | HK1047113A1 (xx) |
| WO (1) | WO2001029082A1 (xx) |
| ZA (1) | ZA200202851B (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001079561A2 (en) * | 2000-04-17 | 2001-10-25 | Liggett Stephen B | Alpha-2 adrenergic receptor polymorphisms |
| US7229756B1 (en) | 2000-10-19 | 2007-06-12 | University Of Cincinnati | Alpha-2B-adrenergic receptor polymorphisms |
| US7211386B2 (en) | 2000-08-10 | 2007-05-01 | University Of Cincinnati | Alpha-2A-adrenergic receptor polymorphisms |
| FI114483B (fi) * | 2001-02-20 | 2004-10-29 | Jurilab Ltd Oy | Menetelmä kohonneen verenpaineen riskin osoittamiseksi ja sen käytöt |
| FI115532B (fi) * | 2002-10-07 | 2005-05-31 | Jurilab Ltd Oy | Menetelmä kardiovaskulaaristen sairauksien riskin havaitsemiseksi |
| AU2003301503A1 (en) * | 2003-12-16 | 2005-07-14 | Centre National De La Recherche Scientifique | Methods and compositions for assaying mutations in nucleic acids |
| TWI260717B (en) * | 2004-05-17 | 2006-08-21 | Mosel Vitelic Inc | Ion-implantation method for forming a shallow junction |
| ATE469245T1 (de) | 2004-09-14 | 2010-06-15 | Univ Colorado | Auf genetischem targeting basierendes verfahren zur behandlung mit bucindolol |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| US5053337A (en) | 1989-10-30 | 1991-10-01 | Neurogenetic Corporation | DNA encoding an α2B -adrenergic receptor |
| CA2145182C (en) * | 1992-09-25 | 2001-09-18 | Jonathan A. Bard | Dna encoding human alpha 1 adrenergic receptors and uses thereof |
-
2000
- 2000-10-20 JP JP2001531880A patent/JP2003512040A/ja active Pending
- 2000-10-20 WO PCT/FI2000/000913 patent/WO2001029082A1/en not_active Application Discontinuation
- 2000-10-20 EP EP00969614A patent/EP1222204A1/en not_active Withdrawn
- 2000-10-20 CA CA002387962A patent/CA2387962A1/en not_active Abandoned
-
2001
- 2001-04-05 US US09/825,923 patent/US6696556B2/en not_active Expired - Fee Related
-
2002
- 2002-04-11 ZA ZA200202851A patent/ZA200202851B/xx unknown
- 2002-11-22 HK HK02108472.8A patent/HK1047113A1/zh unknown
-
2004
- 2004-03-26 US US10/809,860 patent/US20040152637A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20010016338A1 (en) | 2001-08-23 |
| HK1047113A1 (zh) | 2003-02-07 |
| US6696556B2 (en) | 2004-02-24 |
| WO2001029082A1 (en) | 2001-04-26 |
| CA2387962A1 (en) | 2001-04-26 |
| US20040152637A1 (en) | 2004-08-05 |
| JP2003512040A (ja) | 2003-04-02 |
| EP1222204A1 (en) | 2002-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA983148B (en) | Modified TNFÓ, DNA encoding such modified TNFÓ and vacines comprising said TNFÓ and DNA. | |
| PL353139A1 (en) | Plastic bottle, comprising reinforcing means | |
| EP1235846A4 (en) | UTEROGLUBIN-LIKE POLYNUCLEOTIDES, POLYPEPTIDES AND ANTIBODIES | |
| EP1218397A4 (en) | ATTRACTIN-LIKE POLYNUCLEOTIDES, POLYPEPTIDES AND ANTIBODIES | |
| ZA200202851B (en) | A DNA molecule encoding a variant alpha2B-adrenoceptor protein, and uses thereof. | |
| AU2001289517A1 (en) | A novel peptide---human dna cgg repeated associative protein 16.17 and the polynucleotide coding this novel peptide | |
| ZA985414B (en) | DNA encoding a plasminogen activating protein. | |
| HUP0300813A3 (en) | Genes and proteins, and their uses | |
| EP1212415A4 (en) | PGRP-L POLYNUCLEOTIDES, POLYPEPTIDES, AND ANTIBODIES | |
| EP1447411A4 (en) | NEW PROTEIN, ITS DNA AND ITS USE | |
| AU8953401A (en) | A novel polypeptide, a human protein 16.83 ftsh and the polynucleotide encoding the polypeptide | |
| AU8953201A (en) | A novel polypeptide, a human dna methylation protein and the polynucleotide encoding the polypeptide | |
| ZA200005845B (en) | Gene encoding syntaxin interacting protein. | |
| AU7954901A (en) | A novel polypeptide, a centrosome nek-2 binding protein 110.12 and the polynucleotide encoding the polypeptide | |
| AU2001295405A1 (en) | A novel polypeptide, a human dna polymerase delta 12.65 and the polynucleotide encoding the polypeptide | |
| AU8948801A (en) | A novel polypeptide, a human transformer-2-beta protein 29.15 and the polynucleotide encoding the polypeptide | |
| AU4576501A (en) | Ifi206, a novel interferon-induced polypeptide, and nucleic acids encoding the same | |
| ZA977039B (en) | Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof. | |
| AU8169101A (en) | A novel polypeptide, a ubch5 protein 11.44 and the polynucleotide encoding the polypeptide | |
| AU8953801A (en) | A novel polypeptide, a p80-coiline protein 8.8 and the polynucleotide encoding the polypeptide | |
| AU5645501A (en) | Tt virus polypeptide, nucleic acid coding for said polypeptide and uses | |
| EP1066398A4 (en) | GPI-122, NEW PROTEIN ANCHORED TO GLYCOPHOSPHATIDYLINOTISOL | |
| AU2141901A (en) | A novel polypeptide, dna polymerase 13 and the polynucleotide encoding the polypeptide | |
| AU5605601A (en) | A novel polypeptide, a human dna mismatch repair gene protein 8.9 and the polynucleotide encoding the polypeptide | |
| AU2002223376A1 (en) | A novel polypeptide, a human ribosomal protein l7a20.57 and the polynucleotide encoding the polypeptide |